Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €88.44 EUR
Change Today -0.12 / -0.14%
Volume 2.0M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
New York
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 11:37 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by SANOFI (SAN) in the last 6 months

Announced 06/30/15
15.83B for Sanofi
Buyback

Sanofi (ENXTPA:SAN) commences share repurchases on June 30, 2015, under the program mandated by the shareholders in the Annual General Meeting held on May 4, 2015. As per the mandate, the company is authorized to repurchase up to 10% of the share capital such that it does not at any time hold a number of shares representing more than 10% of its issued capital. The shares will be repurchased at a maximum purchase price of €120 per share for €15,832.41 million. The number ...
Read More


SAN's price was unchanged after the transaction was announced on 06/30/15.
 
Announced 05/27/15
245.00M for Retrophin, Inc., Pediatric PRV
Merger/Acquisition

Sanofi (ENXTPA:SAN) made an offer to acquire Rare Pediatric Disease Priority Review Voucher from Retrophin, Inc. (NasdaqGM:RTRX) on May 7, 2015. Sanofi (ENXTPA:SAN) signed an agreement to acquire Rare Pediatric Disease Priority Review Voucher from Retrophin, Inc. (NasdaqGM:RTRX) for approximately $250 million in cash on May 22, 2015. Under the terms of agreement, Retrophin will receive a payment of $150 million, followed by two equal installments of $47.5 million in ...
Read More


SAN's price was unchanged after the transaction was announced on 05/27/15.
Investor / Buyer
Sanofi
Creditor / Lender
Retrophin, Inc.
 
Announced 04/20/15
46.00M for MyoKardia, Inc.
Private Placement

MyoKardia, Inc. announced that it will receive $46,000,001 in a round of funding on April 20, 2015. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.


SAN's price was unchanged after the transaction was announced on 04/20/15.
Investor / Buyer
Casdin Capital, LLC
Cormorant Asset Management, LLC
Cowen Group, Inc.
Sanofi
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €88.44 EUR -0.12

SAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $63.98 USD -0.53
Amgen Inc $155.89 USD +0.17
Bayer AG €121.01 EUR -0.197
Medtronic PLC $73.56 USD +0.04
Novo Nordisk A/S kr369.50 DKK -0.60
View Industry Companies
 

Industry Analysis

SAN

Industry Average

Valuation SAN Industry Range
Price/Earnings 24.2x
Price/Sales 3.2x
Price/Book 2.0x
Price/Cash Flow 16.0x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.